Jade Biosciences (JBIO) Other financing activities (2022 - 2026)

Jade Biosciences' Other financing activities history runs 5 years deep, the most recent figure standing at $45000.0 for Q1 2026.

• Quarterly Other financing activities changed N/A year-over-year to $45000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$190.1 million (changed N/A YoY) and the FY2025 annual result came in at $296000.0, down 3.9% from the prior year.
• Other financing activities was $45000.0 for Q1 2026 at Jade Biosciences, up from -$190.2 million in the prior quarter.
• Across five years, Other financing activities topped out at $704000.0 in Q1 2024 and bottomed at -$190.2 million in Q4 2025.
• A 5-year average of -$18.9 million and a median of $86500.0 in 2023 frame the typical range for Other financing activities.
• Peak annual rise in Other financing activities reached 633.33% in 2023, while the deepest fall reached 290.7% in 2023.
• Jade Biosciences' Other financing activities stood at -$24000.0 in 2022, then jumped by 633.33% to $128000.0 in 2023, then plunged by 409.38% to -$396000.0 in 2024, then sank by 47919.19% to -$190.2 million in 2025, then jumped by 100.02% to $45000.0 in 2026.
• Business Quant data shows JBIO's Other financing activities at $45000.0 in Q1 2026, -$190.2 million in Q4 2025, and -$396000.0 in Q2 2024.